Similar articles

• Comments on the comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease.

  Tordjman K, Jaffe A, Greenman Y, Stern N. Tordjman K, et al. J Clin Endocrinol Metab. 1998 Dec;83(12):4530; author reply 4532-3. doi: 10.1210/jcem.83.12.5322-3. J Clin Endocrinol Metab. 1998. PMID: 9851806 No abstract available.
• The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases.

  Tordjman K, Jaffe A, Grazas N, Apter C, Stern N. Tordjman K, et al. J Clin Endocrinol Metab. 1995 Apr;80(4):1301-5. doi: 10.1210/jcem.80.4.7714104. J Clin Endocrinol Metab. 1995. PMID: 7714104
• Comparison of results of adrenocorticotropic hormone stimulation and low-dose dexamethasone suppression tests with necropsy findings in dogs: 81 cases (1985-1995).

  Van Liew CH, Greco DS, Salman MD. Van Liew CH, et al. J Am Vet Med Assoc. 1997 Aug 1;211(3):322-5. J Am Vet Med Assoc. 1997. PMID: 9262671
• Clinical usefulness of the low dose ACTH test.

  Patel L, Clayton PE. Patel L, et al. J Endocrinol Invest. 1999 May;22(5):401-4. doi: 10.1007/BF03343580. J Endocrinol Invest. 1999. PMID: 10401716 Review. No abstract available.
• The assessment of the hypothalamo-pituitary-adrenal axis in pituitary disease: are there short cuts?

  Dickstein G. Dickstein G. J Endocrinol Invest. 2003;26(7 Suppl):25-30. J Endocrinol Invest. 2003. PMID: 14604063 Review.